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Loss of HP1a results in PCH
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pattern of mitotic defects. HP1b is
functionally related to H4K20me3
deposition and inhibits CTCF distribution,
and its deficiency produces
decompaction of PCH.
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HP1 is a structural component of heterochromatin.
Mammalian HP1 isoforms HP1a, HP1b, and HP1g
play different roles in genome stability, but their pre-
cise role in heterochromatin structure is unclear.
Analysis of Hp1a/, Hp1b/, and Hp1g/ MEFs
show that HP1 proteins have both redundant and
unique functions within pericentric heterochromatin
(PCH) and also act globally throughout the genome.
HP1a confines H4K20me3 and H3K27me3 to regions
within PCH, while its absence results in a global
hyper-compaction of chromatin associated with a
specific pattern of mitotic defects. In contrast,
HP1b is functionally associated with Suv4-20h2 and
H4K20me3, and its loss induces global chromatin
decompaction and an abnormal enrichment of
CTCF in PCH and other genomic regions. Our work
provides insight into the roles of HP1 proteins in het-
erochromatin structure and genome stability.INTRODUCTION
The alteration of pericentric heterochromatin (PCH) organization
and structure have been linked to cell-cycle-progression
defects, DNA damage, chromosomal aberrations, apoptosis,
cancer, and aging (Benayoun et al., 2015; Carone and Lawrence,
2013). PCH is defined by several features including specific his-
tone modifications, structural proteins, histone variants, DNA2048 Cell Reports 21, 2048–2057, November 21, 2017 ª 2017 The A
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et al., 2015). Two histone marks, H3K9me3 and H4K20me3,
have been proposed as being hallmarks of PCH structure (Rea
et al., 2000; Schotta et al., 2004).
H3K9me3 is mainly catalyzed by the histone methyltransfer-
ase Suv39h1 and its close relative Suv39h2 and functions as
a docking site for specific factors (Bannister et al., 2001; Lachner
et al., 2001), whereas H4K20me3 is catalyzed by Su(var)4-20h2
and is directly involved in chromatin compaction and cohesin
recruitment (Hahn et al., 2013). How these marks are distributed
throughout heterochromatin and whether they co-localize in the
same regions within heterochromatic regions are currently
unknown. A key factor in heterochromatin structure is hetero-
chromatin protein 1 (HP1), which was originally described in
Drosophila as a suppressor of position-effect variegation (Eis-
senberg et al., 1990). Mammals harbor three HP1 isotypes
termed HP1a, HP1b, and HP1g (Jones et al., 2000). A growing
body of evidence suggests that the role of HP1 proteins in
genome stability goes beyond heterochromatin structure as
they play a role in gene expression, DNA replication, DNA repair,
cell cycle, cell differentiation, and development (Maison and
Almouzni, 2004). All three isoforms localize to PCH although
HP1b and HP1g are also found in euchromatic regions (Maison
and Almouzni, 2004). HP1 proteins participate in the establish-
ment and propagation of the heterochromatin structure through
their specific binding both to H3K9me3 and Suv39h1 (Bannister
et al., 2001; Lachner et al., 2001). In this sense, HP1b was sug-
gested to act as a bridge between H3K9me3-enriched chro-
matin fibers (Hiragami-Hamada et al., 2016). Interestingly, recent
studies have suggested that HP1-mediated compaction also
involves phase separation from soluble chromatin (Larsonuthors.
creativecommons.org/licenses/by-nc-nd/4.0/).
et al., 2017; Strom et al., 2017). HP1 proteins also act as adapter
molecules that link other factors to heterochromatin such as
Suv4-20h2 or DNA methyltransferases among others (Fuks
et al., 2003; Hahn et al., 2013).
Despite these advances, the question remains as to the rela-
tive contributions of each of HP1 isotype to heterochromatin
organization and structure. This inquiry has been hampered
by the strong functional redundancy of HP1 proteins, the abun-
dance of all three isoforms in PCH foci, and their ability to homo-
and hetero-dimerize (Canzio et al., 2014). Thus, the role of the
three isoforms in heterochromatin has been considered to be
more or less equivalent. However, the fact that the three isoforms
have a distinct pattern of genomic distribution, specific interac-
tion partners, and post-translational modifications, suggests
that they likely perform different functions in cell physiology
(Kwon and Workman, 2011; Maison and Almouzni, 2004). This
possibility has been supported by recent evidence showing a
more direct role of HP1a and HP1g in Suv39h1 function in
PCH than in HP1b (Raurell-Vila et al., 2017). Furthermore, muta-
tional analyses have shown tissue-specific phenotypes in HP1a,
HP1b, and HP1g knockout (KO) mice (Aucott et al., 2008; Brown
et al., 2010; Maksakova et al., 2011; Singh, 2010).
The functional differences between HP1a and HP1b are
particularly relevant as both isoforms are enriched within PCH
and their combined loss abrogates HP1g localization in these
regions (Dialynas et al., 2007). Aiming to understand the specific
role of HP1a and HP1b isoforms in PCH, we analyzed the impact
of each isoform on heterochromatin structure and organization
using mouse embryonic fibroblast (MEF) cells derived from KO
mice. Our studies suggest that HP1a plays a key role as an orga-
nizer of constitutive heterochromatin regions. Loss of HP1a
results in the enrichment of H4K20me3 and H4K27me3 in PCH
foci, whereas HP1b mediates a direct functional link with
H4K20me3 and Suv420h2. Consistent with non-overlapping
roles in PCH organization and structure, each mutant isoform
exhibits a different pattern of H4K20me3 and H3K27me3 distri-
bution in PCH that is associated with different types of mitotic
aberrations. Our studies also suggest that HP1a and HP1b
play opposite roles in CTCF distribution in PCH and other
genomic regions. These studies provide insight into the specific
roles of HP1 isoforms in heterochromatin structure.
RESULTS
Previous studies have suggested that the localization of endog-
enous HP1a and HP1b in PCH was broadly co-incident but not
complete (Dialynas et al., 2007). We first aimed to confirm that
the pattern of distribution of all three isoforms in PCH foci of
NIH 3T3 cells is different. We expressed fluorescence-tagged
HP1 isoforms and performed spectral imaging in PCH, which
enabled us to correlate the intensity distribution of each isoform
(Figure 1A, upper) and their relative localization relative to the foci
center or radial position (Figure 1A, lower). As shown in Figures
1A and S1A–S1C, HP1a and HP1b are enriched in similar regions
of PCH, preferentially toward the center of the foci. However, the
intensity distribution was not identical, thereby suggesting a
distinctive enrichment of both isoforms in PCH structure. HP1g
showed a lower degree of correlation with the other two isoformswith a rather more dispersed distribution within the foci (Fig-
ure 1A). Moreover, the loss of either HP1a or HP1b did not alter
each other’s levels in PCHbut did induce an enrichment of HP1g,
suggesting that it plays an auxiliary role for both isoforms (Fig-
ures S1E and S1F) as has been previously suggested (Raurell-
Vila et al., 2017). The interplay between the isotypes is also
confirmed by the loss of HP1g deposition in PCH upon simulta-
neous loss of HP1a and HP1b (Figure S1D), which has been seen
previously (Dialynas et al., 2007).
HP1a Loss Induces H4K20me3 and H3K27me3
Enrichment in PCH Foci
We first analyzed the histone-modification changes in PCH foci
that are associated with the specific loss of each HP1 isoform.
Toconsider the possibility of cell-cycle-dependent events, we per-
formed the analysis at different stages of the cell cycle. A loss of
each HP1 isoform was correlated with a small decrease in
H3K9me3 and a significant increase (1.5- to 1.7-fold) in
H3K4me3 levels in PCH foci at all stages of the cell cycle (Figures
1B and S2A), thereby confirming that they are redundant with re-
gard to the deposition of these histone modifications. There was
also no significant impact on the DNA methylation levels at major
satellite sequences between HP1a and the other isoforms (Fig-
ures S2B and S2C). In stark contrast, a loss of HP1a, but not
of HP1b or HP1g, resulted in a significant enrichment of
H4K20me3 (around 1.8-fold) and H3K27me3 (around 2-fold) in
the PCH foci during all cell-cycle stages (Figures 1B and S2A).
Notably, increased levels of H4K20me3 were also observed at
other genomic regions as well as the PCH (Figures S2A and
S2D). Chromatin-immunoprecipitation (ChIP) assays confirmed
that both H4K20me3 and H3K27me3 were increased in the major
satellitesofHp1a/MEFscompared towild-type (WT) cells, while
they were decreased in Hp1b/ and Hp1g/ cells (Figure 1C).
To confirm that the changes in both marks were directly
dependent on HP1a, we overexpressed Cre recombinase (R1)
in Hp1a/ MEFs, which excised the promoter-trap Neo
cassette that was used to generate the KO and restored HP1a
gene integrity and expression (noKO) (Figure 2A). As expected,
the re-expression of endogenous HP1a by the nuclease-driven
removal of the Neo cassette (Figures 2B, S3A, and S3B) restored
the levels of both marks in PCH foci. An identical result was ob-
tained upon the overexpression of ectopic HP1a in Hp1a/
MEFs, demonstrating a direct role of HP1a in the control of these
marks (Figures 2C and S3C). Interestingly, the re-deletion of
HP1a (reKO) in noKO cells by FLP recombinase (R2) restored
H3K27me3 levels but did not alter H4K20me3 (Figures 2B and
S3B). The reKO generated a short-truncated form of HP1a (Fig-
ure S3A). To rule out any potential effect of the HP1a short-trun-
cated form on H4K20me3, we knocked down HP1a by short
hairpin RNA (shRNA) in NIH 3T3 cells. Consistently, HP1a loss
resulted in H3K27me3 enrichment in PCH foci (1.6-fold) and no
significant increase in H4K20me3 (Figures 2D, S3D, and S3E)
(Hahn et al., 2013), suggesting a different deposition mechanism
in PCH for both marks. We also knocked down HP1b and
observed, in all cell-cycle stages except for G2/M, a decrease
in both H3K27me3 (25% reduction) and H4K20me3 (20% reduc-
tion) in PCH foci, supporting a direct role for HP1b in H4K20me3
deposition (Figures 2D, S3D, and S3E), which prompted us toCell Reports 21, 2048–2057, November 21, 2017 2049
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Figure 1. Loss of HP1a Induces H4K20me3 and H3K27me3 in PCH Foci
(A) 2D histograms showing HP1-isoform-distribution intensities in cells co-expressing all three HP1 isoforms. Colors represent the observed frequency on a
logarithmic scale, and black lines shows the linear regression of the data points. Pairwise-intensity comparisons between indicated isoforms (top) and each
HP1-isoform intensity plotted against the radial position are indicated with a value from 0 (chromocenter center) to 1 (periphery). Representative images are
shown in Figure S1A. Intensity correlations quantified by Spearman rank-order correlation and linear least-squares regression are included in Figures S1B
and S1C.
(B) Mean intensities of histone marks in the PCH foci from WT cells or MEFs Hp1a/, Hp1b/, and Hp1g/ through the different stages of the cell cycle.
Representative images are shown in Figure S2A. ***p < 0.001.
(C) ChIP of H3K9me3, H4K20me3, and H3K27me3 in major satellites of indicated MEFs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.explore the relationship between HP1b and H4K20me3 in more
detail.
HP1b Is Functionally Linked to H4K20me3 and
Suv420h2
Previous studies with recombinant HP1 proteins have suggested
that all three isoforms may be equivalent in the regulation of
H4K20me3 (Hahn et al., 2013). Interestingly, although we
confirmed that all three isotypes interacted equally well with the
Suv420h2 in nuclear soluble fractions of the transfected cells
(data not shown), we observed a specific interaction between
Suv420h2 and HP1b compared to the other isoforms in extracts
enriched in digested insoluble chromatin upon highly stringent
conditions (Figure 3A). Fluorescence resonance energy transfer
(FRET) experiments confirmed these observations in vivo with a
preferential binding of Suv420h2 to HP1b compared to HP1a
and HP1g (Figures 3B, S4A, and S4C). However, a fluorescence
recovery after a photobleaching (FRAP) analysis of the dynamics
of Suv420h2 in PCH foci of the WT, Hp1a-, Hp1b-, or Hp1g-defi-
cient MEFs showed a more complex picture. The loss of HP1b2050 Cell Reports 21, 2048–2057, November 21, 2017resulted in a decreased turnover of Suv420h2 at PCH and did
not alter the Suv420h2 mobile fraction, whereas the loss of
HP1a resulted in increased turnover of Suv420h2 in PCH
compared to WT (Figures 3C and 3D). The overexpression of
HP1a and HP1b had a small effect on the Suv420h2 residence
time (Figures 3D and S4D). The decreased turnover upon HP1b
loss contrasted with the increase turnover that was observed in
HP1a-deficient cells, indicating an antagonistic role of HP1a
and HP1b in Suv420h2 dynamics. Notably, HP1g loss on
Suv420h2 dynamics induced an effect between HP1a and
HP1b, but its overexpression decreased its mobile fraction (Fig-
ures 3D and S4D). These FRAP analyses suggest that each iso-
form alters Suv420h2 dynamics in PCH in an isoform-specific
manner. Taking our results together, we suggest that the effect
of HP1b is likely to have a more direct role in Suv420h2
dynamics. A functional link between HP1b/Suv420h2 might
also explain the decreased levels of H4K20me3 that were
observed in both Hp1b/ MEFs (Figure 1C) and upon shRNA-
driven HP1b knockdown (Figure 2D). To obtain biochemical sup-
port for such an interaction, we undertook hemagglutinin (HA)
DC
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Figure 2. HP1a Directly Regulates H4K20me3 and H3K27me3 Enrichment in PCH Structure
(A) Generation of noKO and reKO cells from Hp1a/ MEFs. HP1a protein levels were determined by IF and western blot (Figure S3A).
(B) Quantification of relative fluorescence intensity levels of H4K20me3 and H3K27me3 in HP1a KO, noKO, and reKO cells through the cell cycle. Representative
images are shown in Figure S3B. **p < 0.01.
(C) Relative fluorescence intensity levels of H4K20me3 and H3K27me3 in PCH of KO cells upon ectopic expression of either an empty vector or HP1a-RFP.
Representative images of H4K20me3 (right) and H3K27me3 (Figure S3C) are shown. ****p < 0.0001.
(D) Quantification, as in (B), of H4K20me3 and H3K27me3 levels in PCH of NIH 3T3 cells depleted in HP1a or HP1b by shRNA throughout the cell cycle (Figures
S3D and S3E). *p < 0.05, ***p < 0.001.affinity purification of HA-tagged HP1 isoforms, which showed
that HP1b-containing chromatin was 1.5-fold enriched in
H4K20me3 compared to HP1a or HP1g, whereas H3K9me3
was detected at similar levels with all three isoforms (Figures 3E
and S4E). We next tested the ability of each isoform to bind to
H4K20me3 compared to H3K9me3 in peptide pull-downs using
nuclear fractions containingHA-taggedHP1 isoforms (seeExper-
imental Procedures). We performed these pull-downs under two
different buffer conditions, the classical mild Dignam buffer and
thehighly stringent radioimmunoprecipitationassay (RIPA)buffer.
We observed that all three isoforms bound strongly to H3K9me3-
methylated peptide, but only HP1b bound to H4K20me3 resin
(Figure 3F, Dignam). The binding of HP1b to H4K20me3 was
more labile than to H3K9me3 because it was abrogated under
very stringent RIPA conditions (Figure 3F, RIPA). These results
suggested that, despite a strong redundancy between isoforms,
HP1b binds to H4K20me3 with higher affinity than do the other
isoforms. Consistently, re-ChIP experiments of endogenous
HP1 isoforms (first ChIP) and H3K9me3 or H4K20me3 (second
ChIP) of major satellites showed that the ratio H4K20me3/
H3K9me3 in HP1b re-ChIP was clearly higher (1.25) than in
HP1a (1) and HP1g (0.3) (Figure 3G). This increased co-localiza-
tion between HP1b and H4K20me3 was not an exclusive feature
of PCHsince a genome-wideanalysis of previously reportedChIP
sequencing (ChIP-seq) experiments in mouse embryonic stem
cells (ESCs) confirmed a stronger overall correlation between
HP1b and H4K20me3 compared to HP1a (Figure 3H).CTCF Cooperates with HP1a in PCH Organization
Both Suv420h2 and H4K20me3 have been linked to cohesin
enrichment in PCH (Hahn et al., 2013). We next tested whether
the changes in H4K20me3 in Hp1a/ MEFs also alter cohesin
enrichment in PCH. ChIP experiments showed a 2-fold increase
in cohesin levels at PCH inHp1b/MEFs in contrast toHp1a/
and Hp1g/ (Figure 4A). This result suggested that HP1b may
have an inhibitory effect on the accumulation of cohesins in
PCH and that this enrichment was not associated to
H4K20me3 levels. Cohesin distribution has been directly linked
to CTCF, which is a major player in global genomic architecture
(Cuddapah et al., 2009; Rubio et al., 2008). This link and the re-
ported link of CTCF to PCH (Mukhopadhyay et al., 2004; Xiao
et al., 2015) as well as HP1a (Agirre et al., 2015), led us to hypoth-
esize that the H4K20me3-independent cohesin enrichment in
Hp1b/ MEFs may be related to abnormal levels of CTCF in
PCH. Accordingly, we observed that, although the levels of
CTCF in major satellites seem to be under the detection limit of
ChIP in WT, Hp1a/, and Hp1g/ cells, we did detect a signif-
icant enrichment (>7-fold) of CTCF inHp1b/MEFs (Figure 4B).
In contrast, no CTCF enrichment was detected inminor satellites
(Figure 4B). Although CTCF was not detected in PCH by ChIP
analysis, a detailed co-localization analysis of the endogenous
CTCF signal within PCH confirmed the presence of CTCF in
these regions (Figure S5B). These data are consistent with previ-
ous reports (Mukhopadhyay et al., 2004; Xiao et al., 2015) and
indicate that CTCF is present in these regions either in limitingCell Reports 21, 2048–2057, November 21, 2017 2051
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Figure 3. HP1b Is Functionally Linked to Suv420h2 and H4K20me3
(A) Interaction between HA-HP1 isoforms and Suv420h2 in HEK293F cells using HA resin. Inputs (I) and elutions (E) are shown.
(B) Relative quantification of FRET analysis analyzing the interaction between HP1 isoforms (RFP) and Suv420h2 (GFP) in PCH foci of NIH 3T3 cells (Figure S4C)
***p < 0.001. FRET analysis controls are shown in Figures S4A and S4B.
(C) Relative fluorescence intensity of the FRAP assay in PCH foci for Suv420h2-EGFP in WT and HP1 KO cells.
(D) Quantification and statistical analysis of the FRAP experiment in (C) and FRAP in NIH 3T3 cells overexpressing HP1 isoforms (Figure S4D) such as the mobile
fraction (Mobile [%]), and half-time of fluorescence recovery (t1/2). *p < 0.05, **p < 0.01, ***p < 0.001.
(E) H3K9me3/H3 and H4K20me3/H4 levels in affinity purification of HA-tagged HP1 isoforms. Upper: schematic diagram of the experiment. Chromatin fractions
of HEK293F cells expressing HA-taggedHP1 isoformswere digested with Benzonase and affinity purifiedwith HA resin. Levels of H3K9me3 andH4K20me3were
normalized with histones H3 and H4, respectively, and the ratios in HP1b and g pull-downs were quantified (n = 3) and represented relative to HP1a. A repre-
sentative experiment is shown in Figure S4E. *p < 0.05, ***p < 0.001.
(F) Pull-down of HA-tagged HP1 isoforms with H3 or H4 (unmodified or H4K20me3)-biotinylated-streptavidin-agarose performed with HEK293F cell extracts
generated in mild (Dignam) or stringent (RIPA) conditions.
(G) Re-ChIP experiments (n = 3) of endogenous HP1 isoforms (ChIP #1) and H3K9me3 or H4K20me3 (ChIP #2) in major satellites of NIH 3T3 cells. The ratio
H4K20me3/H3K9me3 is shown for each isoform. **p < 0.01, ***p < 0.001.
(H) Correlation of the genome-wide co-localization between H4K20me3 and HP1a or HP1b in mouse ESCs. Boxplot of the log reads of H4K20me3 in the regions
occupied by HP1a and HP1b based on previously published ChIP-seq experiments. ****p < 0.0001.levels or under very specific conditions. Prompted by these data,
we tested whether CTCF interacts with any of the HP1 isoforms
in vitro and in vivo. We found that CTCF bound specifically to2052 Cell Reports 21, 2048–2057, November 21, 2017HP1a in immunoprecipitation experiments (Figure 4D). This
result was supported by FRET as the FRET levels between
HP1a and CTCF were 2-fold higher than for HP1b (Figures 4E
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Figure 4. CTCF Plays a Role in HP1a-Dependent Regulation of PCH Organization
(A) ChIP of cohesin subunit Smc3 in Major satellites of the indicated MEFs. *p < 0.05.
(B) Representative ChIP (n = 3) of CTCF in major satellites, LINE-L1’s promoter, and ORF2 and minor satellites in indicated MEFs. CTCF enrichment is repre-
sented relative to CTCF levels in H19-ICR of WT cells shown in (C). ****p < 0.0001.
(C). CTCF ChIP, as in (B), of H19-ICR CTCF binding sites ICR3 and ICR1 as well as 1 and 2 kb downstream of ICR1. *p < 0.001, **p < 0.005.
(D) HA immunoprecipitation of HEK293F extracts expressing HA-tagged HP1 isoforms, CTCF-EGFP, or both. Inputs and elutions are shown.
(E) FRET-acceptor photobleaching in PCH foci of NIH 3T3 cells between CTCF-EGFP and HP1-RFP isoforms (Figure S5A). **p < 0.01.
(F) CTCF-EGFP distribution in the nucleus of WT of HP1 KO MEFs.
(G) Quantification of IF mean intensities of H4K20me3 and H3K27me3 for shRNA of CTCF in NIH 3T3 cells. ***p < 0.0001.and S5A). Further supporting the antagonism between HP1a and
HP1b in PCH, CTCF EGFP was significantly scarcer in the PCH
foci of HP1a-deficient MEFs, suggesting that HP1a is directly
related to CTCF localization to PCH (Figure 4F). By contrast, a
loss of HP1b induced, in around 45% of cells analyzed, a dra-
matic enrichment of CTCF in PCH regions (Figure 4F), which
was correlated with a global increase in CTCF protein levels
without altering CTCF gene expression (Figure S5D; data not
shown). These data suggest that HP1b loss results in enhanced
spreading of CTCF beyond its normal sites of localization. Con-
firming this hypothesis, CTCF was detected outside the H19imprinting control region (H19-ICR) binding site in Hp1b/ cells
between 1 and 2 kb downstreamof H19-ICR binding site 1 (ICR1)
(Figure 4C). A similar observation was also observed at LINE-L1s
elements (promoter and open reading frame [ORF]2), where a
dramatic increase in CTCF levels was observed inHp1b/ cells.
Together, these evidences indicate that HP1a and HP1b play
opposite roles in CTCF distribution. For completeness, we
explored the role of CTCF in regulating covalent histone modifi-
cations in PCH. As in the case of HP1a, shRNA-mediated deple-
tion of CTCF induced a significant enrichment of H3K27me3
(2.6-fold) in PCH foci without any change in H4K20me3 levelsCell Reports 21, 2048–2057, November 21, 2017 2053
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Figure 5. In Vitro and In Vivo Analysis of Chromatin Compaction in WT and HP1 KO Cells
(A) Upper panels: representative image of MNase digestion upon time for indicated MEFs. Lower panels: representative experiment of the corresponding
southern blot incubated with a [32P]-labeled major satellites probe.
(B) Quantification and intensity versus fragment-size representation of MNase digestion and southern blot line 3 from different experiments (n = 5).
(C) Linker-DNA length calculated from the experiment in (A) and represented in % compared to WT (see Experimental Procedures). *p < 0.05.
(D) Schematic representation of FLIM-FRET methodology used for in vivo chromatin compaction analysis based on H2B-GFP and H2B-mCherry co-expression
(Lle`res et al., 2009). Lower GFP half-life means increased FRET levels and increased chromatin compaction.
(E) Representative images of FLIM-FRET experiments in the indicated MEFs. GFP intensity and GFP fluorophore lifetime-average images are shown.
(F) Relative quantification of chromatin compaction (%FRET) in indicated MEFs using FLIM-FRET methodology (Figures S5E and S5F). Absolute %FRET from
Figure S5E relative to WT values is shown. Controls of these experiments are shown in Figure S5F. *p < 0.05,***p < 0.001.
(G) Analysis of mitotic defects in HP1 KO MEFs.
(H) Representative IF images of the defects included in (H). DAPI (blue), centromere marker, CREST (green), and tubulin (red) are shown.or HP1a localization (Figures 4G and S5C). Altogether, these
evidences suggest that CTCF collaborates with HP1a defining
specific chromatin domains within PCH.
Depletion of HP1a, but Not of HP1b or HP1g, Induces
Decreased Accessibility and In Vivo Hypercompaction
of PCH
A key question concerns the role of HP1 proteins in chromatin
compaction. Such a role is implied by the observation that
H4K20me3 has been directly linked to compaction levels in
PCH foci through cohesins and that HP1 proteins recruit
Suv420h2, which is the enzyme that is responsible for the tri-
methylation of H4K20 (Hahn et al., 2013). Accordingly, we
investigated whether the changes that were observed in the
HP1a- and HP1b-deficient cells were associated to changes in
the levels of compaction of the PCH foci in vitro and in vivo.2054 Cell Reports 21, 2048–2057, November 21, 2017In vitro, we performed a classic micrococcal nuclease (MNase)
digestion of the genome followed by a Southern blot with
an [32P]-labeled probe of the satellite. The loss of HP1a induced
a decrease in accessibility of the PCH foci. By contrast, the loss
of HP1b and, to a lesser extent, of HP1g, induced enhanced
digestion of PCH chromatin DNA by MNase (Figures 5A
and 5B). This effect was not restricted to PCH foci but also
affected the accessibility of chromatin globally. The loss of
HP1a also resulted in around a 20% increase in linker-DNA
length compared to WT cells (Figure 5C). Longer linker DNA
has been associated with higher chromatin compaction (Szer-
long and Hansen, 2011). Next, we investigated the effects of
HP1 loss on chromatin compaction within PCH foci in vivo using
FLIM-FRET assays. This method allowed us to measure the de-
gree of compaction of both PCH foci and the whole genome in
live cells by expressing H2B fused to two different fluorophores
(GFP and RFP) (Lle`res et al., 2009). Higher chromatin compac-
tion was correlated with higher FRET efficiency between H2B-
GFP and H2B-RFP, which resulted in a lower half-life of the
FRET donor GFP (FLIM) (Figure 5D). A FLIM-FRET analysis of
live cells confirmed results that were obtained in vitro because
HP1a deficiency produced a decrease in the GFP half-life
(pamp) as a consequence of a 1.8-fold increase in FRET effi-
ciency. In contrast, HP1b- and HP1g-deficient cells showed no
significant changes in their GFP half-life (Figures 5E, 5F, S5E,
and S5F). These results indicate that HP1a is a key player in
the global organization of PCH by regulating its state of
compaction.
Our in vitro and in vivo studies indicate that, in addition to a
common redundant role of all three isoforms, HP1a and HP1b
have unique isoform-specific roles in genome stability. To test
this hypothesis, we studied the frequency of mitotic abnormal-
ities in WT, Hp1a/, Hp1b/, and Hp1g/ MEFs. Our results
showed that Hp1a/ and Hp1b/ harbored a higher frequency
of aberrations compared to Hp1g/ or Wt cells. The Hp1a/
aberrations were strikingly different to those found in Hp1b/
MEFs. The loss of HP1a resulted in an increased number of mer-
otelic and syntelic attachment defects (Figure 5G), whereas the
loss of HP1b resulted in high frequency of multipolar spindle for-
mation. Interestingly, the loss of HP1g resulted in less frequent
defects that were a mixture of those found in Hp1a/ and
Hp1b/ MEFs, indicating that HP1g shares some redundancy
with the other isoforms (Figures 5G and 5H).
DISCUSSION
Our work suggests that each HP1 isoform makes a distinctive
contribution to the organization and structure of PCH foci. The
individual roles are most clearly manifest in chromosomal abnor-
malities found in isoform-specific mutant MEFs. The increased
frequency of merotelic attachments found in Hp1a/, which re-
sulted from the simultaneous binding of a single kinetochrore to
both spindle poles (Figures 5G and 5H), have been previously
associated to a deficient Clr4/Swi6 function in Schizosaccharo-
myces pombe (Gregan et al., 2007). By contrast, Hp1b/
MEFs showed defects in mitotic spindle multipolarity (Figures
5G and 5H), which may be related to the de-condensed pheno-
type observed in these chromosomes. Our work indicates
that HP1a plays a direct role in restraining H4K20me3 and
H3K27me3 in PCH. Accordingly, we suggest that HP1a acts as
an organizer of PCH in conjunction with CTCF. This is in agree-
ment with the described localization of CTCF in centromeric/
PCH regions (Mukhopadhyay et al., 2004; Rubio et al., 2008).
Our data also suggest that HP1a may recruit CTCF to specific
sites within PCH because the loss of HP1a causes a significant
delocalization of CTCF-EGFP. Notably, we did not detect
CTCF by ChIP in WT, Hp1a/, and Hp1g/ cells (Figure 4B)
although the co-localization experiments of endogenous CTCF
(Figure S5B) and GFP-CTCF distribution and FRET analysis (Fig-
ures 4E and 4F) confirmed the presence of CTCF in PCH as
shown previously (Mukhopadhyay et al., 2004; Xiao et al.,
2015). Our data suggest that HP1b act in opposition to HP1a
with regard to H4K20me3 and H3K27me3 within PCH foci.
Moreover, in Hp1b/ cells, we observed a global enrichmentof CTCF in large regions of the genome including PCH (Fig-
ure 4F), thereby suggesting a role for HP1b in restraining the
localization of CTCF to specific loci and, thereby, likely control-
ling chromatin boundaries. This role is supported by our obser-
vation that loss of HP1b results in enrichment of CTCF outside
its normal confines. Specifically, we observed that, in Hp1b/
cells, CTCF is found in the 6-kb-long LINE-L1 elements at the
promoter and also 2 kb away, at the ORF2 (Figure 4C). A similar
observation was observed at the H19 ICR in Hp1b/ cells (Fig-
ure 4C). The latter result is in keeping with the suggestion that
HP1b may regulate genomic imprinting (Singh, 2016). Because
there does not appear to be any CTCF canonical motifs down-
stream of the H19 ICR or in LINE-L1s, the observed spreading
is unlikely to be related to a direct binding of CTCF to DNA but
more likely dependent on other factors.
Our work suggests that the relationship between H3K27me3
and H4K20me3 with HP1a is different. The increased levels of
H3K27me3, but not of H4K20me3, that were observed upon
downregulation of HP1a suggest that the specific regulation of
H4K20me3 may be restricted to an earlier developmental stage
prior to the specification of the fibroblast lineage. In support of
this idea, the establishment of both HP1a and H4K20me3 seems
to take place at the same time during late development (Wong-
tawan et al., 2011). Recent work has suggested that HP1a has
a more significant role in the establishment of H3K9me3 mark
than in its maintenance (Hathaway et al., 2012). This function
may also be true for H4K20me3 since the re-expression of
HP1a in Hp1a/ could re-establish the H4K20me3 levels in
PCH, but its re-deletion did not have any clear effect (Figures
2A–2C).
We have also revealed an unexpected link between HP1b
and H4K20me3. In vivo HP1b preferentially interacts with
Suv420h2 within the PCH foci and regulates its dynamics.
Consistently, HP1b recognizes H4K20me3-methylated peptides
and HP1b-containing chromatin is enriched in H4K20me3 and
tends to localize with H4K20me3 in major satellites compared
to other isoforms. Moreover, a ChIP-seq analysis shows a
higher genome-wide correlation in ESCs between HP1b and
H4K20me3 compared to HP1a.
One of the most striking observations that we found was the
hypercompaction of the PCH structure in HP1a-deficient cells.
Hypercompaction in HP1a-deficient cells was associated with
an increased enrichment in H4K20me3 and H3K27me3 and a
longer linker DNA (Figure 5C). This result was surprising because
a previous study reported that artificial binding of LacR-tagged
HP1a or HP1b to Lac operon-regulated transgenes resulted in
chromatin compaction (Verschure et al., 2005). These apparently
conflicting observations may be reconciled if one population
of HP1a molecules is involved in PCH compartmentalization
while another plays, along with the other isoforms, amore redun-
dant role.
Based on our data, we propose that, despite a well-estab-
lished functional redundancy between isoforms in PCH, HP1a
and HP1b play different roles in the organization and structure
of PCH. Our studies also suggest amodel of heterochromatin or-
ganization whereby HP1amaintains, together with CTCF, the in-
ternal structure and compaction of PCH foci by restricting the
distribution of H4K20me3 and H3K27me3. These findings offerCell Reports 21, 2048–2057, November 21, 2017 2055
insight into the structural organization of the genome and provide
a perspective on the role of HP1 isoforms and their functional
link with heterochromatin structure, genome organization, and
stability.
EXPERIMENTAL PROCEDURES
FRET, FLIM-FRET, and FRAP Assays
Leica SP5 confocal and Acceptor photo-bleaching methods were used to
measure the FRET in PCH foci. %FRET was calculated taking 100% as the
FRET value that was obtained for GFP-RPF (positive control) and 0% as the
value obtained for the FRET value that was obtained for the donor construct
alone. RFP protein from PCH foci was bleached by using a maximum laser
561 power obtaining 80% of acceptor-intensity bleaching. The FLIM-FRET
experiments were performed as indicated (see Supplemental Experimental
Procedures). All experiments were performed at least in 10 independent as-
says and on 50 different cells. FRAP experiments were carried out as previ-
ously described (see Supplemental Experimental Procedures).
Generation of noKO and reKO Cells
The generation of Hp1a/, Hp1b/, and Hp1g/ mouse and associated
MEFs was previously described (Aucott et al., 2008; Brown et al., 2010; Mak-
sakova et al., 2011). The process of conversion from KO to reKOwas similar as
it was shown for Hp1g/(Brown et al., 2010). Hp1a/ (Cbx5/) (KO) MEFs
were converted into noKO (WT) by the overexpression of Cre recombinase
(R1) in the Hp1a/ MEF cells resulting in the release of the Neo cassette
and the restoration of HP1a gene integrity and expression (noKO). Subse-
quently, the generation of reKO cells was performed by overexpression of
FLP recombinase (R2) in noKO cells, which resulted in a partial deletion of
the Hp1a/ gene and complete abrogation of HP1 expression.
ChIPs and re-ChIPs
ChIPs were performed with 3–5 3 106 cells as previously described (Rodrı´-
guez-Ubreva and Ballestar, 2014). In re-ChIP experiments, the first ChIP
(HP1) was eluted with 10 mM Tris-EDTA (TE) and 20 mM DTT and diluted
20 times in dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA,
16.7 mM Tris-HCl 8.1, 167 mM NaCl, and protease inhibitors) and proceeded
to the second ChIP (H3K20me3 or H3K9me3).
Peptide Pull-Down of HP1 Isoforms
Biotinylated peptides spanning histone H4 residues 1–23 or 1–21 of H3 (un-
modified or H3K9me3) were obtained from Anaspec (Fremont, CA). 100 mg
of peptides were pre-bound to streptavidin agarose (Millipore) and then incu-
bated at 4C overnight (O/N) with nuclear extracts from 293F cells expressing
the HA-tagged HP1 isoforms either prepared according to the Dignam or RIPA
method (see Supplemental Experimental Procedures).
Statistical Analysis
The statistical analysis was performed using a multivariant ANOVA (immuno-
fluorescence [IF] analysis, ChIP-seq, FLIM-FRET) or Student’s t test (rest of
analysis). Graph values represent mean values of n R 3 experiments and
include SEs except in the case of ChIP-seq (SDs). The specific n of each quan-
tification and p values are indicated in the corresponding figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2017.10.092.
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